First genetic marker for MS severity discovered

FHS
June 28, 2023
6:10 pm

Scientists identify the first genetic marker for MS severity, opening the door to preventing long-term disability.

Investment surges, hurdles and emerging innovations in neuroscience – Pharmaceutical Technology

FT Global Pharma and Biotech Summit 2024. Credit: Irena Maragkou Innovation in neuropsychiatry has been dormant for nearly forty years, said Kabir Nath, CEO, Compass

November 11, 2024

Q&A: Novo Nordisk Foundation’s Cellerator CEO Thomas Carlsen digs into $135.4M Danish cell therapy facility

The Novo Nordisk Foundation revealed Thursday it has committed €127 million ($135.4 million) to build a new cell therapy facility in Denmark, which is set

September 22, 2023

Discrimination Rampant in Healthcare; Spring COVID Booster? Lyme Disease Jumps 69%

Note that some links may require registration or subscription. Also please note that in observance of the upcoming holiday, Morning Break will not publish on

February 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.